Managers / Q1 2026
Catawba River Capital
CIK 0001843303 · 4100 CHARLOTTE HIGHWAY, LAKE WYLIE, SC, 29710 · 803-831-0911
Summary
Catawba River Capital reported $208M in U.S.-listed holdings across 24 positions for Q1 2026.
Its largest position, Fidelity Total Bond Etf, represents 11.0% of the portfolio.
Compared with Q4 2025, the fund opened 2 new positions and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 75.6% · $157M
- ETP · 21.0% · $44M
- Closed-End Fund · 3.4% · $7M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| GHMGRAHAM CORP COM | NEW | +117.7K | 117.7K | +$10M | $10M |
| SIMPLIFY INTEREST RATE HEDGE ETF | NEW | +22.4K | 22.4K | +$1M | $1M |
| GPGIComposecure Inc | ADDED | +356.5K | 386.7K | +$6M | $7M |
| FIDELITY TOTAL BOND ETF | ADDED | +261.5K | 503.0K | +$12M | $23M |
| CDRECADRE HOLDINGS | TRIMMED | −199.0K | 260.3K | −$10M | $8M |
| REGNREGENERON PHARMACEUTICALS COM | TRIMMED | −12.6K | 16.8K | −$10M | $13M |
| GQ9SPDR GOLD SHARES | TRIMMED | −30.1K | 42.7K | −$10M | $19M |
| ROADCONSTRUCTION PARTNERS INC COM CL A | TRIMMED | −85.2K | 138.3K | −$9M | $16M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $208M | 24 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $225M | 22 | Feb 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $220M | 20 | Nov 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $197M | 18 | Jul 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $164M | 19 | Apr 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $168M | 18 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $158M | 18 | Oct 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $165M | 20 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $172M | 19 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $142M | 18 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $125M | 20 | Nov 16, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2023 | $125M | 20 | Jul 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $110M | 21 | May 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $95M | 19 | Feb 14, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2022 | $84M | 16 | Oct 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $76M | 15 | Jul 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $151M | 25 | Apr 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $165M | 26 | Jan 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $159M | 27 | Nov 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $159M | 27 | Jul 23, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021REVEALED | $149M | 28 | Apr 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $145M | 31 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.